Mixtard 30 to be discontinued

NovoNordisk is discontinuing all presentations of Mixtard 30 at the end of the year, for commercial reasons. The Penfill cartridges, prefilled InnoLet injector and 10ml vials of the biphasic insulin - a mixture of 30% soluble and 70% isophane insulin - will all be withdrawn on 31 December.

Prescribers should ensure that patients are changed to an alternative insulin preparation before this date. When choosing an alternative insulin, prescribers should take into consideration the equivalent dose and type of insulin, suitability of the device and cost. The decision should be made on a case by case basis.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Logo of the webinar

Cow's Milk Allergy in Practice: free webinar series for UK healthcare professionals

Join us for a short webinar series offering insights...

Close up image of multicoloured capsules

MIMS antidepressants table updated

The MIMS table 'Antidepressants, a guide to switching...

Purple, orange, blue and yellow blood test tubes on a tray.

New advice on vitamin B12 monitoring in patients taking metformin

Patients on metformin treatment with risk factors for...